Commentary – Berashis Cells In Human Umbilical Cord Blood Vs Embryonic Stem Cells
Professor of Pathology and Laboratory Medicine
UMDNJ-New Jersey Medical School
185 South Orange Avenue
Newark, NJ 07103
(Printed in Journal Of Medicine, Volumes 1-4, 2002)
Key Words: Berashis cells, cord blood, embryonic stem cell, human cord blood, therapeutic potential
[Since 1990 we have been aware that human umbilical cord blood had unique cells that displayed reparative ability for various organs in subject mice. We call these cells “Berashis Cells” – beginning cells – to distinguish them from embryonic stem cells, fetal stem cells, adult stem cells, or organ specific stem cells. While much public attention has been given to embryonic stem cell research, this article demonstrates that Berashis Cells from umbilical cord blood have the potential to attain similar therapeutic results.]
Over the past 3 years there have been numerous articles in medical journals, biological journals, and the lay press concerning the great potential of embryonic stem cells (Weissman, 2002). This has provoked extensive controversies, ethical, political, patient rights, attracting numerous television and press reports.
Throughout these articles, the potential for some of the cells found in cord blood collected from normal infants has been essentially ignored. Even though these human cells have been demonstrated to be therapeutically effective both in non-transgenic animal models and in transgenic models, including such diverse diseases as a mouse model for human lupus erythematosus to transgenic mice for Huntington disease, little attention has been paid to this subject.